Diazoxide
Diazoxide is a medicine used to manage certain conditions involving abnormal insulin secretion or elevated blood pressure in specific clinical settings. Oral diazoxide is primarily used to treat hypoglycaemia caused by excessive insulin release, such as in selected cases of hyperinsulinism. It works by inhibiting insulin release from pancreatic beta cells, helping increase blood glucose levels. In some settings, intravenous diazoxide has also been used as a vasodilator for severe hypertension, although availability and clinical use vary by country. Potential adverse effects include fluid retention, nausea, increased blood glucose, and excessive hair growth with prolonged oral treatment. Diazoxide requires medical supervision, with monitoring of blood glucose, fluid balance, and cardiovascular status according to the indication and formulation.
Diazoxide was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Diazoxide, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Diazoxide from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Diazoxide, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
